At a glance
ClinicalIndex Comparison RecordN/ACompleted· 476 enrolled
Drug / intervention
Hearing testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Improving Access to Screening for Hearing Loss After Childhood Cancer - a Novel Community-based Approach
In Brief
A clinical study evaluating Hearing test for Childhood Cancer and Hearing Loss. Completed, enrolled 476 participants across 1 site.
Detailed Summary
The HEAR-study pilots and evaluates a national, low-threshold screening program to detect hearing problems in Swiss adult childhood cancer survivors. Participants will conduct a hearing test in a local hearing aid shop and report about their experiences at the shop in questionnaires and interviews. The screening program will be evaluated using the RE-AIM framework.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChildhood Cancer, Hearing Loss
CountriesSwitzerland
CollaboratorsKrebsforschung Schweiz, Bern, Switzerland
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartJul 2022
Primary CompletionJul 2023
First PostedSep 2023
Study CompletionNov 2024
TodayJul 2026
First PostedSep 13, 2023
Enrollment StartJul 5, 2022
Primary CompletionJul 15, 2023
Study CompletionNov 1, 2024
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 2.8 years ago
Interventions
Hearing testother
Participants visit a local hearing aid shop to assess their hearing function